WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 282
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 342

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 26'832  26'184  25'533  24'883  24'235  17'795  11'961  8'059 
Births 856  849  842  834  825  703  635  446 
Surviving infants 812  805  797  788  779  653  579  388 
Pop. less than 5 years 3'925  3'885  3'846  3'801  3'747  3'138  2'579  1'685 
Pop. less than 15 years 10'804  10'647  10'486  10'323  10'163  8'652  6'195  3'982 
Female 15-49 years 6'638  6'435  6'234  6'034  5'833  3'792  2'451  1'738 

Number of reported cases

(Click for retrospective incidence data for Yemen)
Diphtheria
ChartChart
  555 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  468  815  400  2'177  2'676  18'020 
Mumps
ChartChart
  3'837  5'081  3'306 
Pertussis
ChartChart
  2'529  4'699  2'280  15'332 
Polio*
ChartChart
  722 
Rubella
ChartChart
  162  1'598  706  199  337 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  117  66  80  38  174 
Tetanus (total)**
ChartChart
  117  66  115  38  405 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Yemen)
Vaccine year result method % card seen                                                
BCG 2012  68  DHS   47  47  73  69  64  59  82  99* 
DTP1 2012  77  DHS   47  89  94  94  89  89  88 
DTP3 2012  60  DHS   47  84  88  88  82  81  76  89 
DTP4         
IPV1          12 
HepB_BD         
HepB3 2012  60  DHS   47  84  88  88  82  81  15 
Hib3 2012  60  DHS   47  84  88  88  82  81 
JapEnc         
MCV1          75  75  78  71  71  71  74 
MCV2          49  53  55  48  54 
PCV1          89  93  94  88  81 
PCV3          84  88  88  82  56 
Pol3 2012  59  DHS   47  84  88  88  82  81  76  89 
Rota1          73  79  79  35 
RotaC          67  72  71  23 
RCV1          75 
TT2plus 2012  DHS   47  16  18  18  13  13  31  15 
PAB         
VAD1          48  59  60  49  65 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Yemen)
BCG
ChartChart
  47  73  71  64  59  82  95 
DTP1
ChartChart
  77  82  82  77  78  87  94  18 
DTP3
ChartChart
  69  73  73  67  67  74  84 
HepB3
ChartChart
  69  73  73  67  68  13 
HepB_BD
ChartChart
 
Hib3
ChartChart
  69  73  73  67  66 
IPV1
ChartChart
  12 
MCV1
ChartChart
  67  67  70  63  63  70  69 
MCV2
ChartChart
  41  45  47  40  46 
PAB
ChartChart
  70  70  70  66  66  54  17 
PCV3
ChartChart
  69  73  73  67  41 
Pol3
ChartChart
  63  67  67  68  61  73  84 
RCV1
ChartChart
  67 
RotaC
ChartChart
  52  57  56 

Number of districts in the country 333  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
93 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 23
From 50 to 79% 26
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
MR 9, 18 months; Yes From February 2015
OPV birth; 6, 10, 14 weeks; 9, 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 321  321  306  321  306  306  333 

System performance

Total Nº districts in country number 333  333  333  333  333  333  333 
Nº districts with DTP3 coverage >=80% number 213  256  255  194  189  249  227 
% of districts with DTP3 coverage >=80% From 0 to 100% 64  77  77  58  57  75  68 
Nº districts with measles (MCV1) coverage >=95% number 49  30  36  22  24  20  13 
% of districts with MCV1 coverage >=95% From 0 to 100% 15  11 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22  17  33  37  43  63 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.